Organon (OGN) EBT (2020 - 2026)

Organon (OGN) has reported EBT for 7 consecutive years, with $213.0 million the latest figure, recorded in Q1 2026.

• In Q1 2026, EBT rose 110.89% year-over-year to $213.0 million; the TTM figure through Mar 2026 stood at $537.0 million (down 20.09% YoY), while the FY2025 annual figure was $425.0 million, down 47.34% from the prior year.
• EBT came in at $213.0 million for Q1 2026 at Organon, up from -$148.0 million in the prior quarter.
• The five-year high for EBT was $562.0 million in Q4 2022, with the low at -$148.0 million in Q4 2025.
• Average EBT over 5 years is $217.1 million, with a median of $235.0 million recorded in 2023.
• Across the five-year window, EBT jumped 158.75% in 2024 and sank 214.73% in 2025, its largest moves.
• Year by year, EBT stood at $562.0 million in 2022, then sank by 81.49% to $104.0 million in 2023, then increased by 24.04% to $129.0 million in 2024, then tumbled by 214.73% to -$148.0 million in 2025, then surged by 243.92% to $213.0 million in 2026.
• According to Business Quant data, EBT over the past three periods registered $213.0 million, -$148.0 million, and $243.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.